Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis

A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis

(2010) G. Farina et al.   ARTHRITIS AND RHEUMATISM

Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis

(2009) M. Jinnin et al.   BRITISH JOURNAL OF DERMATOLOGY

Scleroderma

(2009) Armando Gabrielli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Angiogenesis in systemic sclerosis: Impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions

(2008) J. Avouac et al.   ARTHRITIS AND RHEUMATISM

Thrombospondin-1 Deficiency Accelerates Atherosclerotic Plaque Maturation in ApoE −/− Mice

(2008) Rute Moura et al.   CIRCULATION RESEARCH

A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice

(2008) Ying Chen et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Platelet-Derived Growth Factor Signaling Through Ephrin-B2 Regulates Hepatic Vascular Structure and Function

(2008) David Semela et al.   GASTROENTEROLOGY

Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functionsin vitroandin vivo

(2008) Paulius Venalis et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Hypoxia stimulates the autocrine regulation of migration of vascular smooth muscle cells via HIF-1α-dependent expression of thrombospondin-1

(2008) Mayuko Osada-Oka et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin

(2008) J. Wipff et al.   RHEUMATOLOGY